Drug for treating child acute benign myositis

An acute and benign technology, applied in drug combinations, antipyretics, anti-inflammatory agents, etc., can solve problems such as poor acceptance by parents of children, long treatment time, and impact on children's study and life, so as to shorten treatment time and improve group health. reasonable effect

Inactive Publication Date: 2013-02-06
兰英丽
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment takes a long time, restricts activities, and affects children's study and life
Moreover, in order to alleviate symptoms, severe cases have to be treated with intravenous injection of hormones, which has large side effects and poor acceptance by parents of children.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1, the weight ratio of raw materials: Tongjingcao 6g, Loofah 8g, Zoumafeng 8g, Angelica 6g, Pueraria 6g, Papaya 8g, Ophiopogon japonicus 6g, Nanshashen 8g, Paiguling 3g.

Embodiment 2

[0026] Example 2, the weight ratio of raw materials: Tongjingcao 10g, Loofah 15g, Zoumafeng 15g, Angelica 10g, Pueraria 10g, Papaya 15g, Ophiopogon japonicus 10g, Nansha ginseng 15g, Paiguling 6g.

Embodiment 3

[0027] Example 3, the weight ratio of raw materials: Tongjingcao 8g, Luffa 10g, Zoumafeng 10g, Angelica 8g, Pueraria 8g, Papaya 10g, Radix Ophiopogon japonicus 8g, Nansha ginseng 10g, Paiguling 5g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drug for treating child acute benign myositis, aiming to solve the treatment problem of the child acute benign myositis. The drug is prepared from a plurality of Chinese medicinal herbs through processing; and the raw material formula and the weight proportions of the raw materials are as follows: 6-10 parts of aleuritopteris argentea fee, 8-15 parts of loofah sponge, 8-15 parts of six-eared blumea, 6-10 parts of angelica sinensis, 6-10 parts of the root of kudzu vine, 8-15 parts of papaya, 6-10 parts of radix ophiopogonis, 8-15 parts of adenophora tetraphylla and 3-6 parts of fissistigma bracteolatum. Clinical experiments prove that the drug disclosed by the invention is good in curative effect of treating the child acute benign myositis and high in safety, thereby being worth clinical application and popularization.

Description

technical field [0001] The invention relates to the field of pediatric medicine, in particular to a medicine for treating children with acute benign myositis. Background technique [0002] Acute benign myositis in children (benign acute childhood myositis, BACM) is myositis that occurs in children during the course of influenza, also known as acute transient myositis in children, viral myositis, influenza myositis, etc., with a higher incidence in winter and spring. This unique myositis syndrome was first proposed by Lundberg in 1957, and it was found to be related to viral infection, especially influenza B virus infection. In recent years, it has been reported in the literature that the onset of BACM is related to Coxsackie virus, Epstein-Barr virus, HIV Viruses etc. are also relevant. Symptoms and characteristics are mainly manifested as: children are usually in good health. At the beginning of the disease, they all have symptoms of upper respiratory tract infection such ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8968A61P31/16A61P21/00A61P29/00
Inventor 兰英丽陈为宝邰萍
Owner 兰英丽
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products